alemtuzumab
cellectis,sanofi
['balli,01', 'balli,1', 'cellectis']
 presents updated clinical and translational data on balli-01 at . to read the press release&gt;&gt; #data #eha2023 #cellandgenetherapy #data #eha2023 
Cellectis is gene editing the first of its kind, off-the-shelf UCART immunotherapies to fight blood cancers. Community Guidelines: https://t.co/PpAC8G7hQp